Diffuse Midline Glioma H3 K27-altered
📧 Sign up to get email alerts when something new happens for Diffuse Midline Glioma H3 K27-altered.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) [Phase 1]
A Phase I pilot study evaluating S-Gboxin in combination with standard glioblastoma therapy; the trial assessing anti-glioblastoma effects i…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: ONC201 in Adults With Recurrent H3 K27M-mutant Glioma [Phase 2]
Jazz Pharmaceuticals’ ONC201 phase 2 trial in adults with recurrent H3 K27M-mutant diffuse midline glioma has been terminated, and results h…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG) [Phase 1]
A Phase 1 trial evaluating non-invasive focused ultrasound in combination with oral panobinostat for children with progressive diffuse midli…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered
Expanded Access for OKN-007 in patients with diffuse midline glioma (H3 K27-altered) and diffuse intrinsic pontine glioma is no longer avail…